retatrutide and dopamine Retatrutide—A Game Changer in Obesity Pharmacotherapy Do GLP-1 Drugs Affect Love

An important consideration : Women with PCOS who have not been having regular periods may experience a return to fertility when starting GLP-1 treatment and losing weight

What am I getting: 1-month supply of Zepbound (tirzepatide)

It helps control appetite and body weight

The addition of glucagon receptor agonism significantly increases energy expenditure, stimulates fat oxidation, and reduces liver fat producing a more comprehensive metabolic intervention and greater weight loss than either predecessor

They found that intestinal flora may mediate the release of the intestinal hormone GLP-1 through the short-chain fatty acid (SCFA)-GPCR pathway, thereby increasing satiety and slowing gastric emptying, ultimately reducing obesity